471 related articles for article (PubMed ID: 10657215)
1. Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.
Golaz A; Hardy IR; Glushkevich TG; Areytchiuk EK; Deforest A; Strebel P; Wharton M; Sutter RW
J Infect Dis; 2000 Feb; 181 Suppl 1():S203-7. PubMed ID: 10657215
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.
Sutter RW; Hardy IR; Kozlova IA; Tchoudnaia LM; Gluskevich TG; Marievsky V; Deforest A; Wharton M
J Infect Dis; 2000 Feb; 181 Suppl 1():S197-202. PubMed ID: 10657214
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a single dose of diphtheria toxoid among adults in the Republic of Georgia, 1995: immunogenicity and adverse reactions.
Khetsuriani N; Music S; Deforest A; Sutter RW
J Infect Dis; 2000 Feb; 181 Suppl 1():S208-12. PubMed ID: 10657216
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenicity and safety of a tetanus-diphtheria vaccine (adult type): clinical trial in adults].
Gil A; Dal-Ré R; González A; Lasheras L; Aguilar L; del Rey J
Med Clin (Barc); 1995 Feb; 104(4):126-9. PubMed ID: 7898155
[TBL] [Abstract][Full Text] [Related]
5. Assessment of vaccination coverage among adults 30-49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995.
Lewis LS; Hardy I; Strebel P; Tyshchenko DK; Sevalnyev A; Kozlova I
J Infect Dis; 2000 Feb; 181 Suppl 1():S232-6. PubMed ID: 10657220
[TBL] [Abstract][Full Text] [Related]
6. Immune response to diphtheria booster vaccine in the Baltic states.
Rønne T; Valentelis R; Tarum S; Griskevica A; Wachmann CH; Aggerbeck H; Plesner AM; Hansen KG; Ricks P
J Infect Dis; 2000 Feb; 181 Suppl 1():S213-9. PubMed ID: 10657217
[TBL] [Abstract][Full Text] [Related]
7. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
8. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
Trollfors B; Taranger J; Lagergård T; Sundh V
Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
[TBL] [Abstract][Full Text] [Related]
9. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
10. [Combined vaccine against tetanus, diphtheria and polio. A randomized controlled study of immunogenicity and tolerance].
Banzhoff A; Donner-Banzhoff N; Schwenke C; Girgsdies OE; Jilg W
Fortschr Med Orig; 2001 Jan; 118(4):169-72. PubMed ID: 11217682
[TBL] [Abstract][Full Text] [Related]
11. Epidemic diphtheria in the Kyrgyz Republic, 1994-1998.
Glinyenko VM; Abdikarimov ST; Firsova SN; Sagamonjan EA; Kadirova R; Nuorti JP; Strebel PM
J Infect Dis; 2000 Feb; 181 Suppl 1():S98-S103. PubMed ID: 10657199
[TBL] [Abstract][Full Text] [Related]
12. Diphtheria antitoxin levels among children primed with a diphtheria and tetanus toxoids and acellular pertussis vaccine lot with a subpotent diphtheria toxoid component.
Jackson LA; Falls S; Yu O; George J; Pietrobon PJ; Rubanowice D; Froeschle J
J Infect Dis; 2001 Jun; 183(11):1698-700. PubMed ID: 11343223
[TBL] [Abstract][Full Text] [Related]
13. Ukraine, 1992: first assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the Former Soviet Union.
Chen RT; Hardy IR; Rhodes PH; Tyshchenko DK; Moiseeva AV; Marievsky VF
J Infect Dis; 2000 Feb; 181 Suppl 1():S178-83. PubMed ID: 10657210
[TBL] [Abstract][Full Text] [Related]
14. Contraindications to vaccination in the Russian Federation.
Tatochenko V; Mitjushin IL
J Infect Dis; 2000 Feb; 181 Suppl 1():S228-31. PubMed ID: 10657219
[TBL] [Abstract][Full Text] [Related]
15. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
16. Revaccination of adults against diphtheria. II: Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination.
Simonsen O; Klaerke M; Klaerke A; Bloch AV; Hansen BR; Hald N; Hau C; Heron I
Acta Pathol Microbiol Immunol Scand C; 1986 Oct; 94(5):219-25. PubMed ID: 3565028
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults.
McNeil SA; Noya F; Dionne M; Predy G; Meekison W; Ojah C; Ferro S; Mills EL; Langley JM; Halperin SA
Vaccine; 2007 Apr; 25(17):3464-74. PubMed ID: 17270320
[TBL] [Abstract][Full Text] [Related]
18. Epidemic diphtheria in Ukraine, 1991-1997.
Nekrassova LS; Chudnaya LM; Marievski VF; Oksiuk VG; Gladkaya E; Bortnitska II; Mercer DJ; Kreysler JV; Golaz A
J Infect Dis; 2000 Feb; 181 Suppl 1():S35-40. PubMed ID: 10657188
[TBL] [Abstract][Full Text] [Related]
19. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
[TBL] [Abstract][Full Text] [Related]
20. The immune response to booster vaccination against diphtheria toxin at age 18-21 years.
Nahum E; Lerman Y; Cohen D; Salpon R; Danon YL
Isr J Med Sci; 1994 Aug; 30(8):600-3. PubMed ID: 8045740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
